Immunology and Cell Biology - Table of Contents alert Volume 90 Issue 5

SPECIAL FEATURE: The role of type I interferons in regulating innate and adaptive immune responses The innate immune response recognises pathogens and sterile danger signals to generate effector cytokines, such as type I interferons (IFNs), with a high degree of sophistication. The May/June 2012 issue provides a series of reviews of the role of type I IFNs in regulating immune responses. Topics to be covered include the reason for the induction of IFNs, type I IFNs interactions with and regulation of target cells (e.g. T cells, B cells and Th10 cells) in the immune system, and the roles and mechanisms of IFNs in specific organs or diseases. The accompanying web focus presents links to related articles from across Nature Publishing Group to provide more background information about these proteins. TABLE OF CONTENTS Volume 90, Issue 5 (May/June 2012) In this issue News And Commentary Editorial Reviews Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Immunology and Cell Biology is proud to present a Special Feature and web focus on the role of type I IFNs in regulating immune responses, which include the reasons for the presence of IFNs, type I IFNs interactions with target cells in the immune system, and the roles and mechanisms of IFNs in specific organs or diseases. Access the Web Focus today!   News And Commentary Top Stromal cells put the brakes on T-cell responses Troy D Randall Immunol Cell Biol 2012 90: 469-470; advance online publication, November 29, 2011; 10.1038/icb.2011.106 Full Text Editorial Top Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses Paul J Hertzog Immunol Cell Biol 2012 90: 471-473; 10.1038/icb.2012.15 Full Text | PDF Reviews Top Induction of type I IFNs by intracellular DNA-sensing pathways Taner Cavlar, Andrea Ablasser and Veit Hornung Immunol Cell Biol 2012 90: 474-482; advance online publication, March 27, 2012; 10.1038/icb.2012.11 Abstract | Full Text The interferons and their receptors—distribution and regulation Nicole A de Weerd and Thao Nguyen Immunol Cell Biol 2012 90: 483-491; advance online publication, March 13, 2012; 10.1038/icb.2012.9 Abstract | Full Text Modulation of T-cell function by type I interferon David F Tough Immunol Cell Biol 2012 90: 492-497; advance online publication, March 6, 2012; 10.1038/icb.2012.7 Abstract | Full Text Role of type I interferons in the activation of autoreactive B cells Kerstin Kiefer, Michael A Oropallo, Michael P Cancro and Ann Marshak-Rothstein Immunol Cell Biol 2012 90: 498-504; advance online publication, March 20, 2012; 10.1038/icb.2012.10 Abstract | Full Text Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS Ulrich Kalinke and Marco Prinz Immunol Cell Biol 2012 90: 505-509; advance online publication, March 20, 2012; 10.1038/icb.2012.8 Abstract | Full Text Type I interferons in regulation of mucosal immunity Niamh E Mangan and Ka Yee Fung Immunol Cell Biol 2012 90: 510-519; advance online publication, March 20, 2012; 10.1038/icb.2012.13 Abstract | Full Text Interferon signatures in immune disorders and disease Samuel Forster Immunol Cell Biol 2012 90: 520-527; advance online publication, April 10, 2012; 10.1038/icb.2012.12 Abstract | Full Text Original Articles Top Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis Amanda Flies, Tahamtan Ahmadi, Ashley J Parks, Tatiana Prokaeva, Liangping Weng, Sandra Solomon Rolfe, David C Seldin and David H Sherr Immunol Cell Biol 2012 90: 528-539; advance online publication, September 6, 2011; 10.1038/icb.2011.73 Abstract | Full Text ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway Nicholas S Wilson, Becky Yang, Adriana Baz Morelli, Sandra Koernig, Annie Yang, Stefanie Loeser, Denise Airey, Larissa Provan, Phil Hass, Hal Braley, Suzana Couto, Debbie Drane, Jeff Boyle, Gabrielle T Belz, Avi Ashkenazi and Eugene Maraskovsky Immunol Cell Biol 2012 90: 540-552; advance online publication, September 6, 2011; 10.1038/icb.2011.71 Abstract | Full Text Protection against Nippostrongylus brasiliensis infection in mice is independent of GM-CSF Doris S C Shim, Heidi C Schilter, Michelle L Knott, Ranni A Almeida, Robert P Short, Charles R Mackay, Lindsay A Dent and William A Sewell Immunol Cell Biol 2012 90: 553-558; advance online publication, August 16, 2011; 10.1038/icb.2011.69 Abstract | Full Text Short Communication Top LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling Claire J Greenhill, Jodee Gould, Matthias Ernst, Andrew Jarnicki, Paul J Hertzog, Ashley Mansell and Brendan J Jenkins Immunol Cell Biol 2012 90: 559-563; advance online publication, June 14, 2011; 10.1038/icb.2011.56 Abstract | Full Text Corrigendum Top LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling Claire J Greenhill, Jodee Gould, Matthias Ernst, Andrew Jarnicki, Paul J Hertzog, Ashley Mansell and Brendan J Jenkins Immunol Cell Biol 2012 90: 564; 10.1038/icb.2012.25 Full Text Advertisement Did you know these highly cited articles were published in Bone Marrow Transplantation? See what your colleagues have been reading: Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Immunology & Cell Biology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.